eonatal infections, particularly following the diagnosis of intrapartum infection, result in significant morbidity each year. Infants diagnosed with probable sepsis have significantly longer hospital stays and use of antibiotics leading to increasing hospital costs.
More than a decade ago investigators proposed antepartum vaginal washing with chlorhexidine as a means of decreasing group B streptococcus (GBS) colonization rates in neonates. [1] [2] [3] Chlorhexidine disinfection during labor is a simple, cheap, and safe method of reducing GBS colonization without risk for development of bacterial resistance. Another advantage is that it not only can be used in modern labor and delivery suites, but also in the developing world. Intrigued by these initial results and the possibility that chlorhexidine might also reduce the transmission of other potential pathogens, we postulated that this approach may decrease infectious morbidity in neonates caused by vaginal microorganisms. We have previously reported our maternal data.
reduce the use of antibiotics and infectious morbidity in the neonate. 
SUBJECTS AND METHODS

RESULTS
Informed consent was obtained on 1,024 women who were eligible for the study. Of these, 77 were excluded from the analysis for the following reasons: incomplete records (71), the patient was enrolled and subsequently discharged home (3), vaginal wash was not given (2) , and a patient whose infant had anencephaly was inadvertently enrolled Chlorhexidine applied to the vagina intrapartum has been shown to decrease the transmission of GBS to neonates and reduce the GBS colonization of women in the puerperium. Chlorhexidine has also been used as a skin and mucous membrane disinfectant in nurseries for many years. Absorption of chlorhexidine from intact skin is negligible and there is virtually no acute toxicity in animal studies. 7 Concentrations of up to 8% have been used for daily bathing of neonatal monkeys as a means to provide additional evidence of its safety as a skin cleanser. 8 Other studies show that absorption of chlorhexidine through intact skin into the venous blood is negligible. 9 Therefore, chlorhexidine vaginal wash given intrapartum appears to be an inexpensive and safe antimicrobial method for potentially reducing peripartum and neonatal infectious morbidity.
The results of this study indicate that there is no difference in the incidence in the use of antibiotics in the neonatal period or the incidence of neonatal infection. The use of antibiotics appeared to correlate with the length of ruptured membranes as well as presence of IAI. Both of these are known risk factors for neonatal sepsis and pneumonia. 1 In a similar study to ours, Rouse and co-workers showed no difference in neonatal outcomes, including sepsis.
Several reasons could explain our findings. Perhaps, a 10-fold dilution of the stock solution (4%) is not an effective antimicrobial strength. Although this possibility exits, the chlorhexidine concentration used in our study was 300 times the minimum bactericidal concentration for the more common neonatal pathogens. Furthermore, the concentration used in our study was somewhat higher than what has been used in other clinical studies. -3 Another explanation for the lack of any difference between groups is the vehicle used. An aqueous chlorhexidine solution has been used extensively by Christensen 
